Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 24431 | 261 | 31.5 | 70% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 796 | 11443 | DRY POWDER INHALER//MUCOADHESION//JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | HEPARIN CONJUGATE | Author keyword | 8 | 75% | 2% | 6 |
| 2 | ORAL HEPARIN | Author keyword | 8 | 75% | 2% | 6 |
| 3 | MED UIJEONGBU ST MARYS HOSP | Address | 3 | 100% | 1% | 3 |
| 4 | SNAC | Author keyword | 3 | 33% | 3% | 7 |
| 5 | CHEMICAL CONJUGATE | Author keyword | 2 | 43% | 1% | 3 |
| 6 | EA CITHEFOR 3452 | Address | 1 | 38% | 1% | 3 |
| 7 | AMIDATED ACIDS | Author keyword | 1 | 100% | 1% | 2 |
| 8 | ANTI XA ACTIVITY IN VIVO | Author keyword | 1 | 100% | 1% | 2 |
| 9 | ANTI XA ANTI IIA RATIO | Author keyword | 1 | 100% | 1% | 2 |
| 10 | BIOMED ENGN COMP BIOMED ENGN | Address | 1 | 100% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | HEPARIN CONJUGATE | 8 | 75% | 2% | 6 | Search HEPARIN+CONJUGATE | Search HEPARIN+CONJUGATE |
| 2 | ORAL HEPARIN | 8 | 75% | 2% | 6 | Search ORAL+HEPARIN | Search ORAL+HEPARIN |
| 3 | SNAC | 3 | 33% | 3% | 7 | Search SNAC | Search SNAC |
| 4 | CHEMICAL CONJUGATE | 2 | 43% | 1% | 3 | Search CHEMICAL+CONJUGATE | Search CHEMICAL+CONJUGATE |
| 5 | AMIDATED ACIDS | 1 | 100% | 1% | 2 | Search AMIDATED+ACIDS | Search AMIDATED+ACIDS |
| 6 | ANTI XA ACTIVITY IN VIVO | 1 | 100% | 1% | 2 | Search ANTI+XA+ACTIVITY+IN+VIVO | Search ANTI+XA+ACTIVITY+IN+VIVO |
| 7 | ANTI XA ANTI IIA RATIO | 1 | 100% | 1% | 2 | Search ANTI+XA+ANTI+IIA+RATIO | Search ANTI+XA+ANTI+IIA+RATIO |
| 8 | CAS RN 203787 91 1 | 1 | 100% | 1% | 2 | Search CAS+RN+203787+91+1 | Search CAS+RN+203787+91+1 |
| 9 | DELIVERY AGENT | 1 | 50% | 1% | 2 | Search DELIVERY+AGENT | Search DELIVERY+AGENT |
| 10 | DRUG RELEASE IN VITRO | 1 | 50% | 1% | 2 | Search DRUG+RELEASE+IN+VITRO | Search DRUG+RELEASE+IN+VITRO |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | SODIUM N 8 2 HYDROXYBENZOYLAMINOCAPRYLATE | 8 | 75% | 2% | 6 |
| 2 | CHEMICAL CONJUGATE | 6 | 100% | 2% | 4 |
| 3 | CATIONIC ANALOG | 2 | 67% | 1% | 2 |
| 4 | DELIVERY AGENT | 1 | 38% | 1% | 3 |
| 5 | ANTICOAGULANT EFFICACY | 1 | 100% | 1% | 2 |
| 6 | PG 723 | 1 | 100% | 1% | 2 |
| 7 | LOADED POLYMERIC NANOPARTICLES | 1 | 19% | 2% | 4 |
| 8 | CHROMOGENIC SUBSTRATE ASSAYS | 1 | 50% | 0% | 1 |
| 9 | PHOTODYNAMIC THERAPY USE | 1 | 50% | 0% | 1 |
| 10 | SINGLE WALLED VESICLES | 1 | 50% | 0% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Recent advances in search of oral heparin therapeutics | 2012 | 9 | 57 | 56% |
| Oral delivery of new heparin derivatives | 2001 | 0 | 1 | 100% |
| Development of oral heparin therapy for prophylaxis and treatment of deep venous thrombosis | 2001 | 27 | 11 | 45% |
| Advanced Nanocarriers Based on Heparin and Its Derivatives for Cancer Management | 2015 | 1 | 108 | 14% |
| The quest for non-invasive delivery of bioactive macromolecules: A focus on heparins | 2006 | 35 | 108 | 26% |
| Digestive absorption of heparin with alternative formulations | 2002 | 2 | 41 | 61% |
| Strategies for Oral Delivery of Macromolecule Drugs | 2010 | 6 | 82 | 29% |
| Preparation of novel delivery agents for delivery of macromolecular drugs using boric acid mediated amidation of carboxylic acids and amines | 2003 | 2 | 8 | 50% |
| Advances in the formulations of non-injection administration of docetaxel | 2014 | 2 | 42 | 7% |
| Heparin-based nanoparticles | 2010 | 35 | 52 | 10% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | MED UIJEONGBU ST MARYS HOSP | 3 | 100% | 1.1% | 3 |
| 2 | EA CITHEFOR 3452 | 1 | 38% | 1.1% | 3 |
| 3 | BIOMED ENGN COMP BIOMED ENGN | 1 | 100% | 0.8% | 2 |
| 4 | NONCLIN DEV PL BIOL | 1 | 100% | 0.8% | 2 |
| 5 | PHARMA MED GLOBAL PROD STRATEGY | 1 | 50% | 0.8% | 2 |
| 6 | CELL MACROMOL THER Y | 1 | 25% | 1.1% | 3 |
| 7 | CONVERGENT SCI TECHNOL | 1 | 33% | 0.8% | 2 |
| 8 | EA 3452 | 1 | 11% | 2.3% | 6 |
| 9 | CONTROLE QUALIDADE PROD FARMACEUT COSMET | 1 | 50% | 0.4% | 1 |
| 10 | HEMATOL HEMOTHER Y CAMPINAS | 1 | 50% | 0.4% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000210660 | ORAL DELIVERY//ORAL INSULIN DELIVERY//ORAL INSULIN |
| 2 | 0.0000179705 | SODIUM CAPRATE//SUPPOSITORY//ABSORPTION ENHANCER |
| 3 | 0.0000167776 | SULODEXIDE//INHALED HEPARIN//POLYANIONIC CHARGE |
| 4 | 0.0000132197 | LOW MOLECULAR WEIGHT HEPARIN//UNFRACTIONATED HEPARIN//ANTI XA ACTIVITY |
| 5 | 0.0000090487 | CELLULAR INHIBITION//INFECT DIS INVEST SCI//PENTOSAN POLYSULPHATE SODIUM |
| 6 | 0.0000069002 | MUCOPOLYSACCHARIDE POLYSULFATE//CAS 530 78 9//PERFUSED PIG EAR |
| 7 | 0.0000066826 | N TRIMETHYL CHITOSAN CHLORIDE//CHITOSAN NANOPARTICLES//TRIPOLYPHOSPHATE |
| 8 | 0.0000063865 | LIPID NANOCAPSULES//U1066//U646 |
| 9 | 0.0000063162 | HEPARAN SULFATE//OVERSULFATED CHONDROITIN SULFATE//HEPAROSAN |
| 10 | 0.0000059375 | BIOCHEM PHYSIOL NUTR SCITORRE BIOL//HEPARIN LIKE ANTICOAGULANTS//IST PLURIDISCIPLINARE FISIOL UMANA |